ROSE MUELLER: Open Payments
NPI 1336697408 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176 in 10 payments from 8 companies in 2025. Trend: 2023 $225 · 2024 $252 · 2025 $176
Food & beverage: $176
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| ViiV Healthcare Company | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| Gilead Sciences, Inc. | 1 | $16 |
| Ardelyx, Inc. | 1 | $14 |
Products named: REXULTI, MOUNJARO, VAXNEUVANCE, GVOKE HYPOPEN, APRETUDE, IBSRELA.
Industry payments across KS — which companies pay providers there.
